Medicare Enrolled

Dr. Daniel Bandari, M.D.

Neurology · Newport Beach, CA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Speaking/Promotional
3900 W COAST HWY, Newport Beach, CA 92663
9497065580
In practice since 2006 (19 years)
NPI: 1467482216 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Bandari from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bandari? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Bandari

Dr. Daniel Bandari is a neurology specialist in Newport Beach, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Bandari performed 17,560 Medicare services across 173 unique beneficiaries.

Between the years covered by Open Payments, Dr. Bandari received a total of $2,634,133 from 57 pharmaceutical and/or device companies across 2667 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Bandari is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 6% volume in CA $2,634,133 industry payments

Medicare Practice Summary

Medicare Utilization ↗
17,560
Medicare services
Top 6% in CA for neurology
173
Unique beneficiaries
$9
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~924 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Botox injection (Xeomin), per unit
An injection of incobotulinumtoxin A, a botulinum toxin type A product, administered in a quantity of one unit.
16,900 $4 $10
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
464 $136 $467
Chemical nerve block injection, 5+ arm/leg muscles
Injection of a chemical agent to paralyze five or more muscles in the first extremity treated.
74 $154 $650
Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle 74 $71 $201
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
48 $57 $549
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.3% high complexity
97.1% medium
2.6% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$2,634,133
Total received (2018-2024)
Avg $376,305/year across 7 years
Top 0% in CA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
57
Companies
2,667
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$2,545,714 (96.6%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$81,378 (3.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,040 (0.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$378,376
2023
$311,005
2022
$388,279
2021
$335,132
2020
$236,410
2019
$479,979
2018
$504,952

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
EMD Serono, Inc.
$140,295
Biogen, Inc.
$86,373
TG Therapeutics, Inc.
$73,673
Vanda Pharmaceuticals Inc.
$38,704
E.R. Squibb & Sons, L.L.C.
$20,238
Amgen Inc.
$15,862
Celgene Corporation
$2,217
Genentech USA, Inc.
$338
GENZYME CORPORATION
$285
Novartis Pharmaceuticals Corporation
$172
BANNER LIFE SCIENCES, LLC
$55
Genentech, Inc.
$50
Merz Pharmaceuticals, LLC
$45
AstraZeneca Pharmaceuticals LP
$32
Axsome Therapeutics, Inc.
$22
Eisai Inc.
$15
Top 3 companies account for 79.4% of 2024 payments
All-time payments by company (2018-2024) ›
Biogen, Inc.
$845,558
EMD Serono, Inc.
$513,931
GENZYME CORPORATION
$419,259
E.R. Squibb & Sons, L.L.C.
$142,005
Genentech USA, Inc.
$108,905
Celgene Corporation
$94,461
Horizon Therapeutics plc
$91,783
Teva Pharmaceuticals USA, Inc.
$86,736
Alexion Pharmaceuticals, Inc.
$74,317
TG Therapeutics, Inc.
$73,673
Janssen Pharmaceuticals, Inc
$69,697
TG THERAPEUTICS, INC.
$39,024
Vanda Pharmaceuticals Inc.
$38,704
Amgen Inc.
$15,930
CYCLE PHARMACEUTICALS INC
$5,425
Allergan Inc.
$3,984
Acorda Therapeutics, Inc
$3,544
Merz North America, Inc.
$2,654
BANNER LIFE SCIENCES, LLC
$1,056
Novartis Pharmaceuticals Corporation
$1,033
Allergan, Inc.
$561
Merz Pharmaceuticals, LLC
$305
Upsher-Smith Laboratories LLC
$160
UPSHER-SMITH LABORATORIES LLC
$147
Genentech, Inc.
$113
MERZ NORTH AMERICA, INC.
$109
Mallinckrodt LLC
$83
Exeltis, USA Inc.
$74
AbbVie Inc.
$71
Bausch Health US, LLC
$57
ANI Pharmaceuticals, Inc.
$55
Avanir Pharmaceuticals, Inc.
$53
Takeda Pharmaceuticals U.S.A., Inc.
$53
Promius Pharma LLC
$48
Otsuka America Pharmaceutical, Inc.
$43
Alnylam Pharmaceuticals Inc.
$42
Ipsen Biopharmaceuticals, Inc
$41
ABBVIE INC.
$39
Lilly USA, LLC
$36
AstraZeneca Pharmaceuticals LP
$32
Banner Life Sciences, LLC
$31
UCB, Inc.
$29
Supernus Pharmaceuticals, Inc.
$27
Octapharma USA, Inc.
$26
Neurocrine Biosciences, Inc.
$26
Endo Pharmaceuticals Inc.
$23
Mitsubishi Tanabe Pharma America, Inc.
$23
Axsome Therapeutics, Inc.
$22
Kaleo, Inc.
$18
ARBOR PHARMACEUTICALS, INC.
$17
Vertical Pharmaceuticals, LLC
$16
Eisai Inc.
$15
Collegium Pharmaceutical, Inc.
$15
INSYS Therapeutics Inc
$11
Janssen Biotech, Inc.
$11
Pernix Therapeutics Holdings, Inc.
$11
Forte Bio-Pharma LLC
$9
Top 3 companies account for 67.5% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AIMOVIG · AJOVY · AMPYRA · ARZERRA · AUBAGIO · AVONEX · Aimovig · BAFIERTAM · BOTOX · BOTOX THERAPEUTIC · BRIUMVI · COPAXONE · DISEASE STATE · DYSPORT · Dysport · EMGALITY · Evobrutinib · Evzio · GILENYA · Horizant · KESIMPTA · LEMTRADA · LEQEMBI · LORZONE · Leqembi · MAVENCLAD · MAYZENT · MIGRANAL · MS DISEASE STATE · Mavenclad · NASCOBAL · NITYR · NUEDEXTA · Nalocet · Nuedexta · OCREVUS · ONGENTYS · ONPATTRO · Ocrevus · Ocrevus Zunovo · Ozanimod · PANZYGA · PLEGRIDY · PONVORY · PURIFIED CORTROPHIN GEL · Ponvory · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · REMICADE · Radicava · Rebif · SOLIRIS · SPRAVATO · SUBSYS · Soliris · Sunosi · TECFIDERA · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TRINTELLIX · TROKENDI XR · TYSABRI · Trintellix · Tysabri · UBRELVY · UPLIZNA · VUMERITY · Vimpat · Vumerity · WELLBUTRIN XL · XEOMIN · XTAMPZA · Xeomin · ZEMBRACE SYMTOUCH · ZEMBRACE SYMTOUCH SUMATRIPTAN INJECTION · ZEPOSIA · ZOHYDRO ER · Zembrace
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (97%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 0% for neurology in CA.

Looking for a neurology specialist in Newport Beach?
Compare neurologists in the Newport Beach area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists within 10 mi
222
Per 100K population
7.0
County median income
$113,702
Nearest hospital
HOAG MEMORIAL HOSPITAL PRESBYTERIAN
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Bandari is a mixed practice specialist, with above-average Medicare volume (top 6% in CA), with speaking/promotional industry engagement in the top 0% of CA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Bandari experienced with botox injection (xeomin), per unit?
Based on Medicare claims data, Dr. Bandari performed 16,900 botox injection (xeomin), per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Bandari receive payments from pharmaceutical companies?
Yes. Dr. Bandari received a total of $2,634,133 from 57 companies across 2,667 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Bandari's costs compare to other neurologists in Newport Beach?
Dr. Bandari's average Medicare payment per service is $9. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Bandari) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →